Outcomes of Renal Replacement in Mexico (ORReMex)

March 12, 2026 updated by: Olynka Vega, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Clinical Outcomes Study of Mexican Patients With Chronic Kidney Disease on Renal Replacement Therapy

A descriptive, observational, prospective, multicenter study aimed at describing the main clinical outcomes of patients with chronic kidney disease receiving any form of renal replacement therapy in Mexico.

Study Overview

Status

Not yet recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

290

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients with chronic kidney disease undergoing hemodialysis or peritoneal dialysis in the units participating in the project

Description

Inclusion Criteria:

  • Willingness to participate and provision of written informed consent
  • Diagnosis of chronic kidney disease and treatment with hemodialysis or peritoneal dialysis for ≥3 months
  • Availability of a medical record containing information on the study variables
  • Receiving care at one of the participating centers

Exclusion Criteria:

  • Life expectancy <3 months due to a cause unrelated to chronic kidney disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
CKD on RRT
Patients with chronic kidney disease undergoing renal replacement therapy (RRT) in Mexico

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
All-cause mortality
Time Frame: From enrollment in the study until death from any cause or end of follow-up, assessed up to 3 years.
The occurrence of death from any cause during the follow-up period, as documented in the patient's medical record
From enrollment in the study until death from any cause or end of follow-up, assessed up to 3 years.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hospitalizations per patient-year
Time Frame: From enrollment until the end of follow-up, assessed up to 3 years
The number of hospitalizations recorded during the study follow-up, expressed per patient-year
From enrollment until the end of follow-up, assessed up to 3 years
Infection rate
Time Frame: From enrollment until the end of follow-up, assessed up to 3 years
The number of documented infection episodes during the follow-up period, as recorded in the medical records, expressed per patient-year.
From enrollment until the end of follow-up, assessed up to 3 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2026

Primary Completion (Estimated)

April 1, 2026

Study Completion (Estimated)

April 1, 2029

Study Registration Dates

First Submitted

March 9, 2026

First Submitted That Met QC Criteria

March 12, 2026

First Posted (Actual)

March 16, 2026

Study Record Updates

Last Update Posted (Actual)

March 16, 2026

Last Update Submitted That Met QC Criteria

March 12, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NMM-5533-25-28-1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

It has not yet been determined whether individual participant data will be shared. Decisions regarding data sharing will be made after completion of the study and publication of the primary results, in accordance with institutional policies and applicable regulations.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Kidney Disease - Stage V

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe